MGMeenaloshini Gopalakrishnan

Meenaloshini Gopalakrishnan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Meenaloshini Gopalakrishnan has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An Integrated In Silico Investigation of Anti-Pancreatic Cancer Phytochemicals from Ipomoea batatas Using Network Pharmacology, Molecular Docking, Molecular Dynamics Simulation, MM-PBSA, and DFT Analyses

    by K.B. Sharveshram, Meenaloshini Gopalakrishnan, Karthikha Sumathi, Sri Velegatla, Ramya Govindarajulu, Hemalatha Kanagarajan

    Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignancies, characterized by poor prognosis, late diagnosis, and limited therapeutic efficacy of current epidermal growth factor receptor (EGFR)-targeted therapies due to drug resistance and adverse effects. Natural products represent an important source of structurally diverse bioactive molecules for the development of novel anticancer agents. This study aimed to systematically investigate the therapeutic potential of Ipomoea batatas phytochemicals against pancreatic cancer using an integrated computational approach.,Methods: Five major phytochemicals from I. batatas (cis-zeatin, lubimin, ipomeamarone, ipomine, and 7-hydroxycostol) were screened through network pharmacology, protein–protein interaction analysis, Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment. Molecular docking was performed against EGFR (PDB ID: 1IVO), followed by comparative analysis with the reference inhibitor erlotinib. The lead compound was further evaluated using 100 ns molecular dynamics (MD) simulations, MM-PBSA binding free-energy calculations, density functional theory (DFT), and in silico ADMET and toxicity prediction.,Results: Network pharmacology identified EGFR, AKT1, MAPK1, JAK2, and PIK3CA as key hub proteins associated with pancreatic cancer progression. KEGG enrichment highlighted significant modulation of the PI3K–Akt, MAPK, JAK–STAT, and EGFR tyrosine kinase inhibitor resistance pathways. Among the screened phytochemicals, cis-zeatin demonstrated the highest docking affinity toward EGFR (-8.0 kcal/mol), exceeding that of erlotinib (-7.5 kcal/mol), and established multiple stabilizing hydrogen-bond and hydrophobic interactions within the active site. Molecular dynamics simulations confirmed the structural stability of the EGFR–cis-zeatin complex throughout the 100 ns trajectory, while MM-PBSA analysis supported favorable binding energetics. DFT calculations revealed favorable electronic characteristics consistent with molecular stability and reactivity. Furthermore, cis-zeatin exhibited desirable drug-likeness, high gastrointestinal absorption, compliance with Lipinski's rule of five, and an overall acceptable predicted safety profile.,Conclusion: The integrated computational findings identify cis-zeatin as a promising natural EGFR-targeting scaffold capable of modulating multiple pancreatic cancer-associated signaling pathways.

  • Open Access

    Perioperative management of brain hemorrhage: Advances in anesthetic strategies and translational medicine

    by Meenaloshini Gopalakrishnan, Karthikeyan Elumalai, Nandhini Jayaprakash

  • Open Access

    From Lab to Life: How Research Becomes Treatment

    by Hemalatha Kanagarajan, Parvatha Raja Kumaran V S, Meenaloshini Gopalakrishnan

    This book discusses the tactics involved in biomedical discoveries from the basic laboratory ‎research ‎to real-world implementation. It highlights the relevance of scientific discovery ‎with patient care, safety, efficacy, regulation and ‎clinical understanding essential for ‎therapeutic development of the molecule. It may either be research connected to the ‎vaccination, small organic chemicals or biologicals which carries ‎forward the research to ‎become treatment. The principles involved in the progression of the laboratory research, ‎human trials, and post-marketing ‎applications followed by the real-world setting. The ‎stakeholders for this book are students, clinical research experts, and healthcare innovators ‎to ‎understand the latest therapeutic development. ‎

  • Open Access

    Integration of graphene quantum dots with 3D scaffolds for precision medicine and regenerative applications

    by Yuvaraj Muthu, Meenaloshini Gopalakrishnan, Prabakaran Sankar, Elizabeth Rani Edwin, Karthikeyan Elumalai


  • Multi-strategic approaches to healthcare wastewater treatment amidst COVID-19 pandemic in India—a narrative review

    by Meenaloshini Gopalakrishnan, Karthikha Vijayakumar Sumathi, Sri Vaishnavi Velegatla, Yuvaraj Muthu, Prabakaran Sankar, Hemalatha Kanagarajan

    The COVID-19 pandemic has led to a significant increase in healthcare waste, including personal protective equipment (PPE), pharmaceutical residues, and viral pathogens, posing environmental and public health risks, especially in emerging economies like India. This study evaluates the environmental and health risks of healthcare wastewater during the pandemic, focusing on emerging pollutants like microplastics from PPE and pharmaceutical residues. A literature review analyzed the environmental impact, including the presence of SARS-CoV-2 RNA, antimicrobial residues, and microplastics, and explored wastewater-based epidemiology (WBE) for tracking viral spread and antimicrobial resistance (AMR). The review found that traditional wastewater treatments are insufficient for emerging pollutants, while advanced methods like ozonation, nanofiltration, and hybrid approaches offer better removal efficiencies but are hindered by high costs. Cost analysis reveals that some effective methods may not be economically viable in low-resource settings. Future research should enhance treatment efficiency, reduce costs, and explore the long-term impacts of microplastics and pharmaceutical residues. The study highlights the need for robust, cost-effective wastewater management strategies to address the growing environmental and health risks in the post-pandemic era. Graphical Abstract

  • Open Access

    Mechanistic insights and therapeutic applications of Hinokitiol in Inflammation, Antimicrobial therapy, and Cancer

    by Karthik K Karunakar, Binoy Varghese Cheriyan, Ramaiyan Velmurugan, Meenaloshini Gopalakrishnan, Karthikha Vs


  • Advances in nephroprotection: the therapeutic role of selenium, silver, and gold nanoparticles in renal health

    by Karthik K. Karunakar, Elizabeth Rani Edwin, Meenaloshini Gopalakrishnan, Binoy Varghese Cheriyan, Velmurugan Ramaiyan, V. S. Karthikha, Jerry Peliks Justin

    Renal toxicity is a disorder that causes considerable issues in healthcare systems world, highlighting the critical importance of creating alternative treatments. Metallic nanoparticles have recently emerged as promising therapeutic agents for nephroprotection because of their remarkable properties. Numerous disciplines, including medicine, biotechnology, and the food industry, are currently investigating and exploring metallic nanoparticles, such as selenium, silver, and gold, with promising outcomes. In this overview, we provide the most current findings on cutting-edge nephroprotection through metallic nanoparticles, especially selenium, silver, and gold nanoparticles. While outlining the benefits, we outline possible methods for developing metallic nanoparticles, characterization techniques, and nephroprotection therapies. Selenium nanoparticles (SeNPs) minimize oxidative stress, a primary cause of nephrotoxicity through cell regeneration which protects kidneys. Silver nanoparticles (AgNPs) have anti-inflammatory capabilities that help alleviate kidney damage and nephrotoxicity. Gold nanoparticles (AuNPs), which are biocompatible and immune-modifying, reduce inflammation and promote renal cell regeneration, indicating nephroprotective advantages. Renal protection via the use of metallic nanoparticles represents a promising new frontier in the fight against kidney disease and other renal disorders. Metallic nanoparticles of selenium, silver, and gold can protect the kidneys by lowering oxidative stress, reducing inflammation, and improving cell repair. Through their mechanisms, these nanoparticles effectively safeguard and repair kidney function, making them suitable for treating renal diseases. The potential applications of selenium, silver, and gold nanoparticles, as well as their complex modes of action and renal penetration, provide fresh hope for improving renal health and quality of life in patients with kidney disease. The current study highlights therapeutic ability, stability, nephroprotection, and toxicity profiles, as well as the importance of continuous research in this dynamic and evolving field.


  • Top Cited Papers
    Open Access

    A review on selenium nanoparticles and their biomedical applications

    by K.K. Karthik, Binoy Varghese Cheriyan, S. Rajeshkumar, Meenaloshini Gopalakrishnan